DE60112744D1 - Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens - Google Patents
Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigensInfo
- Publication number
- DE60112744D1 DE60112744D1 DE60112744T DE60112744T DE60112744D1 DE 60112744 D1 DE60112744 D1 DE 60112744D1 DE 60112744 T DE60112744 T DE 60112744T DE 60112744 T DE60112744 T DE 60112744T DE 60112744 D1 DE60112744 D1 DE 60112744D1
- Authority
- DE
- Germany
- Prior art keywords
- prophylaxis
- diagnosis
- treatment
- morbus crohn
- ompc antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/245—Escherichia (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/575,061 US7138237B1 (en) | 2000-05-19 | 2000-05-19 | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
PCT/US2001/016032 WO2001089361A2 (en) | 2000-05-19 | 2001-05-17 | Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60112744D1 true DE60112744D1 (de) | 2005-09-22 |
DE60112744T2 DE60112744T2 (de) | 2006-06-14 |
Family
ID=24298769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60112744T Expired - Lifetime DE60112744T2 (de) | 2000-05-19 | 2001-05-17 | Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens |
Country Status (8)
Country | Link |
---|---|
US (4) | US7138237B1 (de) |
EP (1) | EP1285271B1 (de) |
JP (1) | JP4917728B2 (de) |
AT (1) | ATE302411T1 (de) |
AU (1) | AU2001261741A1 (de) |
DE (1) | DE60112744T2 (de) |
ES (1) | ES2247115T3 (de) |
WO (1) | WO2001089361A2 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138237B1 (en) * | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
WO2003053220A2 (en) | 2001-12-17 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
US20040053263A1 (en) * | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
US20040076960A1 (en) * | 2002-10-18 | 2004-04-22 | Taylor Kent D. | Methods of using a NOD2/CARD15 haplotype to diagnose Crohn's disease |
US7018188B2 (en) | 2003-04-08 | 2006-03-28 | The Procter & Gamble Company | Apparatus for forming fibers |
WO2004091372A2 (en) * | 2003-04-11 | 2004-10-28 | Cedars-Sinai Medical Center | Methods of assessing crohn’s disease patient phenotype by i2, ompc and asca serologic response |
US7662569B2 (en) * | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
US7759079B2 (en) * | 2004-05-13 | 2010-07-20 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
FR2876798A1 (fr) * | 2004-10-14 | 2006-04-21 | Univ Clermont Auvergne | Diagnostic et traitement de la maladie de crohn |
US11268149B2 (en) | 2004-12-08 | 2022-03-08 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease |
EP2270512B1 (de) * | 2004-12-08 | 2016-03-23 | Cedars-Sinai Medical Center | Verfahren zur Diagnose von Morbus Crohn |
US10544459B2 (en) | 2004-12-08 | 2020-01-28 | Cedars-Sinai Medical Center | Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease |
JP4577083B2 (ja) * | 2005-04-28 | 2010-11-10 | 味の素株式会社 | クローン病の診断方法 |
US7873479B2 (en) | 2005-12-01 | 2011-01-18 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
US20070282714A1 (en) * | 2006-04-27 | 2007-12-06 | Snocap, Inc. | System, method and computer program product for providing an e-commerce interface on a web page to facilitate e-commerce involving digital assets |
US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
US20100094560A1 (en) * | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
US8685741B1 (en) | 2007-03-07 | 2014-04-01 | Nestec S.A. | Methods for diagnosing irritable bowel syndrome |
US8486640B2 (en) | 2007-03-21 | 2013-07-16 | Cedars-Sinai Medical Center | Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease |
AU2009314259B2 (en) | 2008-11-11 | 2015-06-11 | Nestec S.A. | Methods for prediction of inflammatory bowel disease (IBD) using serologic markers |
US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
WO2010075579A2 (en) | 2008-12-24 | 2010-07-01 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy |
CN102341705B (zh) * | 2009-03-05 | 2015-08-19 | 味之素株式会社 | 克罗恩氏病诊断试剂 |
EP2419529B1 (de) | 2009-04-14 | 2015-05-20 | Nestec S.A. | Prognostik entzündlicher darmerkrankung |
JP5736370B2 (ja) | 2009-06-25 | 2015-06-17 | ネステク ソシエテ アノニム | 過敏性腸症候群の診断方法 |
BR112012002957A2 (pt) * | 2009-08-14 | 2016-04-12 | Procter & Gamble | conjunto de matriz de fiação e método para formação de fibras com o uso do dito conjunto. |
WO2011060098A1 (en) | 2009-11-10 | 2011-05-19 | Prometheus Laboratories Inc. | Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis |
US8445215B1 (en) | 2010-07-23 | 2013-05-21 | Nestec S.A. | Assays and methods for the detection of Crohn's disease |
KR20140008397A (ko) | 2011-02-17 | 2014-01-21 | 네스텍 소시에테아노님 | 항-TNFα 약물에 대한 자가항체 검출을 위한 검정법 |
WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
CA2839792A1 (en) | 2011-05-10 | 2012-11-15 | Nestec S.A. | Methods of disease activity profiling for personalized therapy management |
EP2710383B1 (de) | 2011-05-16 | 2017-01-11 | The University of Newcastle | Leistungsfähigkeit eines Biomarkerpanels für Reizdarmsyndrom |
SG11201401536QA (en) | 2011-10-21 | 2014-05-29 | Nestec Sa | Methods for improving inflammatory bowel disease diagnosis |
AU2013326070A1 (en) | 2012-10-05 | 2015-04-23 | Société des Produits Nestlé S.A. | Methods for predicting and monitoring mucosal healing |
KR20210157418A (ko) | 2013-03-27 | 2021-12-28 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전 |
EP4105236A1 (de) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anti-tl1a (tnfsf15) antikörper zur behandlung von entzündlichen darmerkrankungen |
CA2932571A1 (en) | 2013-12-03 | 2015-06-11 | Nestec S.A. | Methods for predicting post-operative recurrence of crohn's disease |
WO2017079653A2 (en) | 2015-11-06 | 2017-05-11 | Vetica Labs, Inc. | Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals |
EP3430172A4 (de) | 2016-03-17 | 2019-08-21 | Cedars-Sinai Medical Center | Verfahren zur diagnose einer entzündlichen darmerkrankung durch rnaset2 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
US5681699A (en) | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
US5691151A (en) * | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
US5932429A (en) * | 1996-04-12 | 1999-08-03 | Cedars-Sinai Medical Center | Methods of diagnosing clinical subtypes of crohn's disease |
US5916748A (en) | 1996-04-12 | 1999-06-29 | Cedars-Sinai Medical Center | Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis |
US5874233A (en) | 1996-04-12 | 1999-02-23 | Cedars-Sinai Medical Center | Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis |
US5968741A (en) * | 1997-04-11 | 1999-10-19 | Cedars-Sinai Medical Center | Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis |
GB9806449D0 (en) * | 1998-03-25 | 1998-05-27 | Peptide Therapeutics Ltd | Attenuated bacteria useful in vaccines |
US6218129B1 (en) * | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
US7138237B1 (en) * | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
-
2000
- 2000-05-19 US US09/575,061 patent/US7138237B1/en not_active Expired - Lifetime
-
2001
- 2001-05-17 AU AU2001261741A patent/AU2001261741A1/en not_active Abandoned
- 2001-05-17 ES ES01935666T patent/ES2247115T3/es not_active Expired - Lifetime
- 2001-05-17 WO PCT/US2001/016032 patent/WO2001089361A2/en active IP Right Grant
- 2001-05-17 JP JP2001585609A patent/JP4917728B2/ja not_active Expired - Fee Related
- 2001-05-17 AT AT01935666T patent/ATE302411T1/de not_active IP Right Cessation
- 2001-05-17 EP EP01935666A patent/EP1285271B1/de not_active Expired - Lifetime
- 2001-05-17 DE DE60112744T patent/DE60112744T2/de not_active Expired - Lifetime
-
2006
- 2006-11-17 US US11/561,024 patent/US7993865B2/en not_active Expired - Fee Related
-
2009
- 2009-01-12 US US12/352,578 patent/US7993866B2/en not_active Expired - Fee Related
- 2009-01-12 US US12/352,579 patent/US7993867B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60112744T2 (de) | 2006-06-14 |
ES2247115T3 (es) | 2006-03-01 |
US7993866B2 (en) | 2011-08-09 |
US7138237B1 (en) | 2006-11-21 |
US20090221007A1 (en) | 2009-09-03 |
JP2004526122A (ja) | 2004-08-26 |
EP1285271B1 (de) | 2005-08-17 |
EP1285271A4 (de) | 2003-07-23 |
EP1285271A2 (de) | 2003-02-26 |
US7993867B2 (en) | 2011-08-09 |
WO2001089361A3 (en) | 2002-03-28 |
US20090221006A1 (en) | 2009-09-03 |
JP4917728B2 (ja) | 2012-04-18 |
WO2001089361A2 (en) | 2001-11-29 |
US7993865B2 (en) | 2011-08-09 |
AU2001261741A1 (en) | 2001-12-03 |
US20070161065A1 (en) | 2007-07-12 |
ATE302411T1 (de) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60112744D1 (de) | Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens | |
LTPA2020001I1 (lt) | Anti-IL-12 antikūnai, kompozicijos, būdai ir panaudojimas Krono patologijai gydyti | |
DE69318420D1 (de) | Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung | |
DE69129302T2 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
HUP0301877A2 (hu) | Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek | |
DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
DK1385864T3 (da) | Anti-VEGF-2-antistoffer | |
ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
DE69129460T2 (de) | Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK | |
WO2006067792A3 (en) | Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease | |
ATE398137T1 (de) | Porphyromonas gingivalis antigene zur diagnose und behandlung von periodontitis | |
DE59709109D1 (de) | Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease | |
DE60336063D1 (de) | Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren | |
DE69524242T2 (de) | Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren | |
DK0994353T3 (da) | Forbedret fremgangsmåde til allergidiagnostik | |
ATE360212T1 (de) | Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie | |
CA2297694A1 (en) | Antibodies and diagnostic methods for the diagnosis of pestviruses | |
DE69827800D1 (de) | Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose | |
ATE206138T1 (de) | Helicobacter pylori antigen | |
AP1638A (en) | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. | |
ATE299739T1 (de) | Neurokinin b vorläufer aus menschlicher plazenta | |
WO2022212742A3 (en) | Anti-ara h 2 antibodies and uses thereof | |
TH131300B (th) | ตัวแปรอิมมูโนกลูบูลินและการใช้สิ่งนั้น | |
ATE321875T1 (de) | Serologisches in-vitro-verfahren zur diagnose von infektiöser endokarditis | |
EP1821104A3 (de) | Verfahren zur Diagnose der Effizienz xenotypischer Antikörperbehandlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |